David Patience Insider Profile
11 Followers
David Patience, CFO at TriSalus Life Sciences, holds 261.11K shares in TriSalus Life Sciences (Ticker: TLSI), holds 65.33K shares in Accelerate Diagnostics (Ticker: AXDXQ).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+28.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
CFO
Roles that David Patience holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Patience
David Patience's Trading History
TriSalus Life Sciences
Jul 06, 2026
CFO
Uninformative Sell
65.34K
$1.31M
Accelerate Diagnostics
Apr 02, 2025
―
Uninformative Buy
9.36K
$653.28
List of latest transactions for each holding click on a transaction to see David Patience's performance on stock
You May Also Like
David Patience insider profile FAQ
What is the percentage of profitable transactions made by David Patience?
The percentage of profitable transactions made by David Patience is 50%.
What is the average return per transaction made by David Patience?
The average return per transaction made by David Patience is 28.10%.
What stocks does David Patience hold?
David Patience holds: TLSI, AXDXQ stocks.
What was David Patience’s latest transaction?
David Patience latest transaction was an Uninformative Sell of $65.34K.
What was David Patience's most profitable transaction?
David Patience’s most profitable transaction was an Informative Buy of TLSI stock on May 18, 2026. The return on the trade was 59.40%.
What is David Patience's role in TriSalus Life Sciences?
David Patience's role in TriSalus Life Sciences is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.